Nephrolithiasis: Clinical Trials

9 trials for Nephrolithiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 unknown. 9 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Unknown 9
Phase 21Unknown 1

Follow Nephrolithiasis: new trials by email Literature Review of Nephrolithiasis trials Research Report on Nephrolithiasis

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Enhanced Versus Extended Preoperative Antibiotic Prophylaxis Regimens for Retrograde Intrarenal Surgery in High Infectious Risk Patients
Enhanced regimen, Extended regimen - Renal Stone
Phase 3UnknownMansoura University2802022-05-012022-11-14
Ultra-Mini Versus Standard Percutaneous Nephrolithotomy For Management Of Renal Calculi. A Randomized Controlled Trial.
percutaneous nephrolithotomy, ultra-mini percutaneous nephrolithotomy - Stone, Kidney
Phase 3UnknownAin Shams University602021-02-282021-02-21
Holmium Vs Trilogy Kidney Stones GUY's 1-2
Fragmentation of calculi with 100 W Holmium laser or LithoClast Trilogy EMS and 1.5 mm x 440 mm probe, according to randomization. - Kidney Stone, Kidney Calculi
Phase 3UnknownHospital Regional de Alta Especialidad del Bajio1162020-09-302020-09-22
Effect of Furosemide on ESWL Outcomes for Renal and Ureteral Calculi
Furosemide 40 mg, Conventional Treatment - Urolithiasis, Nephrolithiasis
Phase 3UnknownShiraz University of Medical Sciences5002020-07-012022-03-08
Mirabegron And Ureteral Stent-related Pain (MAP) Trial
Mirabegron 50 MG, Placebo oral tablet - Nephrolithiasis
Phase 3UnknownUnity Health Toronto1422020-02-032020-02-26
ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study
ACTHAR Gel (adrenocorticotropic hormone) - Sarcoidosis, Hypercalcemia Due to Sarcoidosis
Phase 2 / Phase 3UnknownAlbany Medical College102015-02-012015-01-26
Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney
LithoSpace Extracorporeal Shockwave Lithotripter - Kidney Stones
Phase 3UnknownAdvance Shockwave Technology GmbH202010-06-012011-06-01
Alfuzosin for Medical Expulsion Therapy of Ureteral Stones
Alfuzosin, nifedipine, doxazosin - Kidney Stones
Phase 3UnknownUnited States Naval Medical Center, San Diego2402008-01-012012-04-27
Effects of the Use of Adjuvant Drugs After Extracorporeal Shockwave Lithotripsy (ESWL) in Renal Calculus
Tamsulosin - Renal Calculi
Phase 3UnknownUniversity of Sao Paulo General Hospital1362006-08-012010-10-06

Narrower conditions

Kidney Calculi (5)  ·  Glomerulonephritis (1)  ·  Hypercalcemia (1)  ·  Hypercalciuria (1)  ·  Kidney Diseases (1)  ·  Nephritis, Interstitial (1)  ·  Nephrocalcinosis (1)  ·  Renal Insufficiency, Chronic (1)  ·  Sarcoidosis (1)  ·  Sepsis (1)  ·  Ureterolithiasis (1)  ·  Urinary Calculi (1)  ·  Urolithiasis (1)

Broader conditions

Female Urogenital Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (9)  ·  Male Urogenital Diseases (9)  ·  Urogenital Diseases (9)  ·  Urologic Diseases (9)  ·  Kidney Diseases (8)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Urolithiasis (8)  ·  Calculi (6)  ·  Pathological Conditions, Anatomical (6)  ·  Urinary Calculi (5)  ·  Pathologic Processes (2)  ·  Calcinosis (1)  ·  Calcium Metabolism Disorders (1)

Interventions

Adrenocorticotropic Hormone (1)  ·  Doxazosin (1)  ·  Furosemide (1)  ·  Nephrolithotomy, Percutaneous (1)  ·  Nifedipine (1)  ·  Prazosin (1)  ·  Tamsulosin (1)  ·  alfuzosin (1)  ·  mirabegron (1)

Sponsors

Advance Shockwave Technology GmbH (1)  ·  Ain Shams University (1)  ·  Albany Medical College (1)  ·  Hospital Regional de Alta Especialidad del Bajio (1)  ·  Mansoura University (1)  ·  Shiraz University of Medical Sciences (1)  ·  United States Naval Medical Center, San Diego (1)  ·  Unity Health Toronto (1)  ·  University of Sao Paulo General Hospital (1)

Countries

United States (3)  ·  Egypt (2)  ·  Brazil (1)  ·  Canada (1)  ·  Iran (1)  ·  Mexico (1)

Top investigators

Amr A Elsawy (1)  ·  Brian K. Auge, M.D. (1)  ·  Dariush Irani, MD (1)  ·  Ehab Nour (1)  ·  Marc A Judson, MD (1)  ·  Michael Ordon, MD, FRCSC (1)  ·  Miguel Srougi, MD (1)  ·  Sean P. Stroup, M.D. (1)

Results publications

PMID 10360498, PMID 24707884, PMID 27758119, PMID 28608192, PMID 29649900, PMID 30961854, PMID 31177306, PMID 31588790, PMID 40210001, PMID 41460253